AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimisil-M2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Sansill Formulations

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimisil-M2 Tablet SR

Diabetam-Duo SR tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabetam-Duo SR should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications like kidney disease, vision loss, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a fast-acting glucose source (e.g., sugary sweets or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. Do not use Diabetam-Duo SR if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver impairment. Inform your doctor of any history of heart disease before starting treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should consult their physician prior to use. Regular blood glucose monitoring and potential blood tests (blood counts and liver function) will be recommended by your doctor.

Uses of Glimisil-M2 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimisil-M2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Glimisil-M2 SR tablets should be administered with food.

Common Side effects of Glimisil-M2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimisil-M2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not chew, crush, or divide it. Consume Glimisil-M2 SR tablets with food.

How Glimisil-M2 Tablet SR works:

Glimisil-M2 SR tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness in peripheral tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimisil-M2 Tablet SR and alcohol poses a significant safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimisil-M2 Tablet SR during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimisil-M2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimisil-M2 SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glimisil-M2 SR tablet use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimisil-M2 Tablet SR cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, Glimisil-M2 Tablet SR is typically initiated at a low dosage; however, it's contraindicated in patients with severe liver dysfunction.

What if you forget to take Glimisil-M2 Tablet SR :

Should you forget a Glimisil-M2 Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimisil-M2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimisil-M2 Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimisil-M2 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Glimisil-M2 Tablet SR and seek immediate medical attention.
Glimisil-M2 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glimisil-M2 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimisil-M2 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimisil-M2 SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimisil-M2 Tablet SR and alcohol is unsafe. Alcohol can further lower blood sugar, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimisil-M2 Tablet SR
54
MRP 66
18% off